Patients want to know:
“Is this treatment safe? Will it work for me?”
Learn practical strategies for discussing anti-TFPI therapy with confidence in this free #Hemophilia webinar: rebrand.ly/9482SM
Could you be the next Editor-in-Chief of RPTH? ISTH is seeking a new Editor-in-Chief for Research and Practice in Thrombosis and Haemostasis (RPTH).
Learn more and apply: isth.org/page/RPTHSearch
ISTH retweeted
XVII CONGRESO ARGENTINO DE HEMOSTASIA Y TROMBOSIS | VIII CURSO EDUCACIONAL DE LA ISTH
Recomendamos a todos nuestros socios y socias este evento científico que se llevará a cabo en Buenos Aires, Argentina, del 7 al 10 de Octubre de 2026.
Más información en sochihem.cl/v3/articulo?id=5…
ISTH retweeted
🩸La relación entre #trombofilia, terapia antitrombótica y salud reproductiva plantea retos en la práctica clínica.
La #SETH lidera este consenso multisociedad con criterios compartidos para abordar fertilidad, pérdidas gestacionales, patología vascular placentaria, trombosis durante la gestación y anticoncepción.
👉 Consulta el consenso: seth.es/consenso-terapia-ant…
#DíaMundialdelaTrombosis #WorldThrombosisDay #WTDay26 #ConsensoMujer #SaludReproductiva #fertilidad #placenta #embarazo #puerperio #anticoncepción #trombosis #trombofilia #mujer
ISTH retweeted
Brand new data led by @ta_sussman @SKoroukian Vu Long re risk of thromboembolism with melanoma therapy from our group. 2-3 fold worsening of OS with VTE/ATE should be concerning to all @JTHjournal @isth
sciencedirect.com/science/ar…
ISTH retweeted
Replying to @SysmexEurope
@SysmexEurope - Managing Thrombotic Risk in Pregnancy – How the Lab May Help
@isth
hemostasistoday.com/voices/s…
#HemostasisToday
ISTH retweeted
#NATA webinar | #WorldThrombosisDay
13 October - 18:00 CEST
Heparin-induced thrombocytopenia (HIT)
@JerroldLevy: Anticoagulation in suspected HIT in the ICU
Corinne Frère: HIT and cardiac surgery with cardiopulmonary bypass
🔗 nataonline.com/monthly-live-…
#HIT #Thrombosis #WTD2026
Children are not simply small adults. Developmental differences in the hemostatic system introduce important considerations for evaluating bleeding and thrombotic conditions in pediatric & neonatal patients. How do these differences inform clinical decision-making?
Learn more during this SSC on the Case: bit.ly/4y9Hpo6
Women can face unique blood clot risks across different stages of life, but gaps in recognition and diagnosis still remain. Our new ISTH Pulse Podcast episode in honor of #WorldThrombosisDay highlights women’s health, thrombosis risk, warning signs and opportunities to improve: soundcloud.com/you/insights/… #WTDay26
🎙️ Catch up on the latest episodes of the ISTH Pulse Podcast factor mimetics miniseries. Across Episodes 2 and 3, Geoffrey Barnes, Jeffrey Weitz, Mike Sharma, and Deborah Siegal explore the evolving role of factor mimetics in hemophilia A care.
🎧 Listen to Episodes 2 and 3: pod.link/1555328920
Join us as experts explore what we know about emerging ITP therapies, how they target disease immunopathogenesis, and what their introduction could mean for clinical practice. You’ll leave with a clearer understanding of:
✔️Emerging therapeutic targets
✔️Efficacy and safety considerations
✔️Monitoring and durability of response
✔️How clinical practice may need to evolve
👉 Save your spot: bit.ly/4xklIBs
On #WorldHeartDay, the ISTH joins the global call for action to improve cardiovascular health. ❤️
🚨 Happening today! How could gene editing shape the future of hemostasis?
Register/watch here: bit.ly/4qxgXCG
We're thrilled to announce a new ISTH Pulse Podcast miniseries! In the first episode, we explore why next-generation mimetic therapies are needed & key questions shaping their role in hemophilia care: soundcloud.com/isth_thepulse…
What could the next generation of factor mimetics mean for hemophilia A care? In the latest episode of the ISTH Pulse Podcast, Julia Sandrin Gauer is joined by Sanjay Ahuja and Allison Wheeler to explore emerging therapies including Mim8, NXT007 and Inno8.
🎧: bit.ly/47dF4NU





















